The largest database of trusted experimental protocols

Donkey antirabbit igg h l alexa fluor 594

Manufactured by Thermo Fisher Scientific
Sourced in United States

Donkey antirabbit IgG(H+L) Alexa Fluor 594 is a secondary antibody conjugated with the Alexa Fluor 594 fluorescent dye. It is designed to detect and visualize rabbit primary antibodies in various immunoassay applications.

Automatically generated - may contain errors

4 protocols using donkey antirabbit igg h l alexa fluor 594

1

Immunofluorescent Detection of LCN2 and Receptor

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunofluorescent double labelling, sections were incubated with 15% normal donkey serum at room temperature for 30 min and then incubated overnight at 4°C with primary antibodies. After washing, sections were incubated with secondary antibodies for 2 h. The primary antibodies were polyclonal goat anti-LCN2 (1:200 dilution, R&D system), polyclonal rabbit anti-SLC22A17 (marker for LCN2 receptor, 1:50 dilution, Abcam), polyclonal mouse anti-GFAP (1:400 dilution, Millipore), monoclonal mouse anti-neuronal nuclei (NeuN; 1:100 dilution, Millipore) and polyclonal goat anti-Iba1 (1:500 dilution, Abcam) or rabbit anti-Iba-1 (1:500 dilution, Wako). The secondary antibodies were donkey antigoat IgG(H+L) Alexa Fluor 594 (1:500 dilution, Invitrogen), donkey antirabbit IgG(H+L) Alexa Fluor 594 (1:500 dilution, Invitrogen), donkey antimouse IgG(H+L) Alexa Fluor 488 (1:500 dilution, Invitrogen), donkey antirabbit IgG(H+L) Alexa Fluor 488 (1:500 dilution, Invitrogen) and donkey antigoat IgG(H+L) Alexa Fluor 488 (1:500 dilution, Invitrogen). The double labelling was analysed using a fluorescence microscope.
+ Open protocol
+ Expand
2

Immunofluorescence Staining of Brain Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sections were permeabilized in 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA), blocked in CAS-BlockTM Histochemical Reagent (Thermo Fisher Scientific, Waltham, MA, USA), and then stained with the following antibodies: polyclonal rabbit anti-calbindin (1:500, CB38, Swant, Switzerland) and monoclonal mouse anti-fetuin-A (diluted 1:100, Santa Cruz Biotechnology, Dallas, TX, USA). Sections were then incubated with donkey anti-mouse IgG (H + L) Alexa Fluor 488 or donkey anti-rabbit IgG (H + L) Alexa Fluor 594 (1:300, Invitrogen, Carlsbad, CA, USA) for 2 h at room temperature. FluoroshieldTM with DAPI (Sigma-Aldrich, St. Louis, MO, USA) was used for nuclear staining. Stained brain sections were analyzed with an immunofluorescence microscope (Thermo Fisher Scientific, InvitrogenTM EVOSTM M7000 Imaging System, USA). These stained brain sections were quantified with the ImageJ software v1.52a (Bethesda, MD, USA).
Cells were plated onto sterilized glass coverslips placed in 6- or 24-well culture plates. Cells were fixed with 4% PFA, permeabilized with 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, USA), blocked with CAS-BlockTM Histochemical Reagent (ThermoFisher Scientific, Waltham, MA, USA), and stained as described above.
+ Open protocol
+ Expand
3

Fibrinogen Knockdown Assay Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
FGA siRNA (assay# s5115), FGB siRNA (s5119) FGG siRNAs (s5179) and negative control #1 (#4390843) were obtained from Thermo Fisher Scientific. Each siRNA concentration was titrated in 96-well tissue culture plate, in triplicates, with final concentrations ranging from 0 nm to 49 nM, in 7 nm increment. Briefly, each siRNA was dissolved in 200 μl of OPTI-MEM I Reduced Serum Medium (Gibco) mixed in equal volume of Lipofectamine RNAiMAx (Invitrogen, Carlsbad, CA, United States) with a final amount of 0.64 μl/well. siRNA and Lipofectamine were left for 5 min at room temperature for complexes to form, according to manufacturer’s instructions, and then were added to each well, mixed gently and incubated at 37°C for 48 h. At 48 h, cells were fixed in ice-cold 4% PFA. Rabbit polyclonal antibodies against human fibrinogen chain Aα antibody (20645-1-AP), fibrinogen chain Bβ antibody (16747-1-AP), and fibrinogen chain γ antibody (15841-1-AP) from Proteintech (Rosemont, IL, United States), were used. Donkey anti-Rabbit IgG H&L (Alexa Fluor®594) (A21207, Invitrogen, Carlsbad, CA, United States) were used as a secondary antibody. Immunofluorescence was processed as described above.
+ Open protocol
+ Expand
4

Microglial Activation and Regulation Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary antibodies used in this study included polyclonal goat anti‐Iba1 (Abcam, 1:400), polyclonal rabbit anti‐Iba1 (Abcam, 1:400), polyclonal rabbit anti‐heme oxygenase‐1 (Enzo, 1:500), monoclonal mouse anti‐TLR9 (Abcam, 1:400), polyclonal rabbit anti‐TLR9 (GeneTex, 1:400), polyclonal goat anti‐GFAP (Abcam, 1:400), monoclonal rabbit anti‐Darpp‐32 (Cell Signaling, 1:100), polyclonal rabbit anti YM‐1 (Abcam, 1:200), monoclonal mouse anti‐NeuN (MERCK, 1:400), monoclonal mouse anti‐Arg1 (Santa Cruz, 1:200), polyclonal rabbit anti‐CD16 (Abcam, 1:200), polyclonal rabbit anti‐iNOS (Abcam, 1:200), polyclonal rabbit anti‐CD36 (GeenTex, 1:2000), monoclonal rabbit anti‐CD204 (Abcam, 1:2000), And polyclonal rabbit anti‐Nrf2 (Proteintech, 1:2000).
The secondary antibodies used in this article for immunofluorescence staining included donkey anti‐rabbit IgG (H + L) Alexa Fluor 488, donkey anti‐rabbit IgG (H + L) Alexa Fluor 594, donkey anti‐mouse IgG (H + L) Alexa Fluor 488, donkey anti‐mouse IgG (H + L) Alexa Fluor 594, donkey anti‐goat IgG (H + L) Alexa Fluor 488, and donkey anti‐goat IgG (H + L) Alexa Fluor 594, all obtained from Invitrogen.
The drugs used in this study included CpG ODN1826 and CpG ODN2138 (InvivoGen), clodronate liposomes, control liposomes (Liposoma Technology), and brusatol (Sigma‐Aldrich).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!